Heska (HSKA) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Heska Reports First Quarter Results
May 4, 2018 8:00 AM EDTLOVELAND, Colo., May 4, 2018 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its first quarter ended March 31, 2018.
First Quarter 2018 Highlights with Prior Year Comparison:
Net revenue up 10.8% to $32.8 millionCore Companion Animal ("CCA") segment revenue up 12.8% to $26.8 million  Point of Care Laboratory Consumables revenue up 17%  Point of Care Imaging revenue up 33%Other Vaccines and Pharmaceuticals ("OVP") segment revenue up 3% to $5.9 million Consolidated gross margin down 4.1 percentage points to 40.6% due to OVP product mix (impact of... More